Literature DB >> 3498378

[Complement activation following head and brain trauma].

P Becker, S Zieger, U Rother, H Lutz, P M Osswald.   

Abstract

The prognosis for a patient with a severe head injury is dependent not only upon the location and the degree of this trauma, but also upon additional complications. For example, disseminated intravascular coagulation (DIC) can occur because of the thromboplastic activity of the damaged brain tissue that enters the circulation. The complement (C) system is activated by certain enzymes that cleave the clotting factors. Therefore, after head injuries we searched for C activation because it could result in the adult respiratory distress syndrome (ARDS). Patients and methods. We had two groups of patients: (1) 23 with large destruction and (2) 13 with little destruction of the brain tissue. Eighteen patients in group 1 and 8 in group 2 had isolated brain trauma. Blood samples were taken--upon arrival at the hospital and then 1, 3, 7, 12, 24, and 48 h later; after that we took weekly blood samples up to the completion of their treatment in the intensive care unit. We measured the total hemolytic serum C activity (CH50), activation of alternative pathway hemolysis (APH50), cleavage products C3a and C3d, and total protein. Furthermore, we studied the coagulation parameters of the extrinsic (prothrombin time) and intrinsic (partial thromboplastin time) pathways and fibrinogen content. From the patients records we extracted clinical parameters such as neurological status, intracranial pressure, pathological details on computer tomography hemoglobin and arterial-alveolar oxygen difference. Results. Figure 1 shows the different reactions of the C system in both groups: while patients of group 1 suffered from a decrease in total and alternative hemolytic activity, the other group increases in both parameters.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498378

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.

Authors:  Inge A M van Erp; Iliana Michailidou; Thomas A van Essen; Mathieu van der Jagt; Wouter Moojen; Wilco C Peul; Frank Baas; Kees Fluiter
Journal:  Neurotherapeutics       Date:  2022-10-12       Impact factor: 6.088

2.  Human brain trauma severity is associated with lectin complement pathway activation.

Authors:  Daiana De Blasio; Stefano Fumagalli; Franca Orsini; Laura Neglia; Carlo Perego; Fabrizio Ortolano; Elisa R Zanier; Edoardo Picetti; Marco Locatelli; Nino Stocchetti; Luca Longhi; Peter Garred; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-09       Impact factor: 6.200

3.  Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.

Authors:  Inge A M van Erp; Thomas A van Essen; Kees Fluiter; Erik van Zwet; Peter van Vliet; Frank Baas; Iain Haitsma; Dagmar Verbaan; Bert Coert; Godard C W de Ruiter; Wouter A Moojen; Mathieu van der Jagt; Wilco C Peul
Journal:  Trials       Date:  2021-12-04       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.